Communiqués de presse
Archives
InnaVirVax strengthens patent protection of VAC-3S immunotherapy
2012/06/18
The Company reaches a new stage of development with the filing of a new European patent application for VAC-3S aimed at protecting the immune system of patients infected with HIV-1.
In order to receive
Genopole® press releases®,
please provide your coordinates
to Press Service
